Ausdal Financial Partners’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$267K Sell
3,153
-673
-18% -$54.3K 0.01% 869
2026
Q1
$271K Sell
3,826
-444
-10% -$33.2K 0.01% 823
2025
Q4
$337K Sell
4,270
-1,349
-24% -$107K 0.02% 677
2025
Q3
$463K Buy
+5,619
New +$442K 0.02% 580
2025
Q2
– Sell
-2,745
Closed -$220K – 718
2025
Q1
$220K Buy
+2,745
New +$228K 0.02% 583
2016
Q1
– Sell
-3,198
Closed -$137K – 708
2015
Q4
$137K Buy
+3,198
New +$141K 0.07% 250

Other funds holding MET

Ausdal Financial Partners's MET Position: Q2 2026 in Review

Ausdal Financial Partners reduced its MetLife (MET) stake by 18% in Q2 2026, selling an estimated $54.3K and leaving 3,153 shares worth $267K. The position accounts for 0.01% of the portfolio, ranked #869.

Ausdal Financial Partners first reported a position in MET in Q4 2015 and has held it in 6 quarters since. The position peaked at $463K in Q3 2025. 1,450 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Ausdal Financial Partners held 3,153 shares of MetLife worth $267K as of Q2 2026.
  • Ausdal Financial Partners sold 673 MetLife shares in Q2 2026, an estimated $54.3K.
  • MetLife made up 0.01% of Ausdal Financial Partners's portfolio in Q2 2026, its #869 holding.
  • Ausdal Financial Partners first reported a position in MetLife in Q4 2015 and has held it in 6 quarters since.
  • Ausdal Financial Partners's MetLife position peaked at $463K in Q3 2025.
  • 1,450 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Ausdal Financial Partners's 13F filing for Q2 2026, filed 14 Aug 2026.